Electroacupuncture inhibits IL-17/IL-17R and post-receptor MAPK signaling pathways in a rat model of chronic obstructive pulmonary disease

Abstract

Objective:

Interleukin (IL)-17, as a T-helper 17 cell (Th17) cytokine, plays a key role in chronic obstructive pulmonary disease (COPD) pathophysiology including chronic inflammation and airway obstruction, which lead to decreased pulmonary function. The aim of this study was to investigate the effect of acupuncture on IL-17, its receptor (IL-17R) and the mitogen-activated protein kinase (MAPK) signaling pathway, in a rat model of COPD.

Methods:

The COPD model was induced in Sprague Dawley rats by exposure to cigarette smoke for 12 weeks. The model rats were treated with electroacupuncture (EA) at BL13 and ST36. The lung function and histology of the rats were observed. IL-17, tumor necrosis factor (TNF)-α, and IL-10 were detected by enzyme-linked immunosorbent assay (ELISA) in bronchoalveolar lavage fluid (BALF) and in plasma. The leukocytes and macrophages in the BALF were counted. The expression levels of IL-17R were assayed in lung tissue by real-time polymerase chain reaction (PCR), western blotting, and immunohistochemistry. MAPK signaling pathway molecules including c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK)1/2 and p38, and their phosphorylated forms, were observed in the lung by western blotting.

Results:

Compared with the control group rats, lung function decreased and there was a severe inflammatory infiltration of the pulmonary parenchyma in the COPD rats. EA effectively improved lung function and alleviated the inflammatory infiltration in the lungs of COPD rats. EA also reversed the elevated total leukocyte and macrophage counts, the high levels of IL-17 and TNF-α, and the low IL-10 content in COPD rats. Meanwhile, EA downregulated the increased mRNA and protein expression of IL-17R, and significantly inhibited the elevated levels of phosphorylated JNK, ERK1/2, and p38 in the lungs of COPD rats.

Conclusion:

Our results suggest that the protective effects of acupuncture therapy on the lungs of COPD rats are likely related to inhibition of IL-17/IL-17R and the post-receptor MAPK signaling pathways.

Keywords

acupuncture chronic obstructive pulmonary disease electroacupuncture IL-17 IL-17R MAPK signaling pathway

Get full access to this article

View all access options for this article.

References

Mirza

Clay

Koslow

, et al. COPD guidelines: a review of the 2018 GOLD report. Mayo Clin Proc 2018; 93(10): 1488–1502.

King

PT.

Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer. Clin Transl Med 2015; 4: 26.

Tuder

Petrache

Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest 2012; 122: 2749–2755.

Le Rouzic

Pichavant

Frealle

, et al. Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations. Eur Respir J 2017; 50(4): 1602434.

Di Stefano

Caramori

Gnemmi

, et al. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol 2009; 157(2): 316–324.

Doe

Bafadhel

Siddiqui

, et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 2010; 138(5): 1140–1147.

Chang

Al-Alwan

Audusseau

, et al. Genetic deletion of IL-17A reduces cigarette smoke-induced inflammation and alveolar type II cell apoptosis. Am J Physiol Lung Cell Mol Physiol 2014; 306(2): L132–L143.

Bozinovski

Seow

Chan

, et al. Innate cellular sources of interleukin-17A regulate macrophage accumulation in cigarette smoke-induced lung inflammation in mice. Clin Sci (Lond) 2015; 129(9): 785–796.

Laan

Cui

Hoshino

, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999; 162: 2347–2352.

10.

Chang

Al-Alwan

Risse

PA.

TH17 cytokines induce human airway smooth muscle cell migration. J Allergy Clin Immunol 2011; 127(4): 1046–1053.

11.

Chen

Pociask

McAleer

, et al. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS ONE 2011; 6(5): e20333.

12.

Chang

, et al. Identification and functional characterization of a novel interleukin 17 receptor: a possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway. Cell Signal 2006; 18(8): 1287–1298.

13.

Neumeister

Kuhlemann

Bauer

Effect of acupuncture on quality of life, mouth occlusion pressures and lung function in COPD. Med Klin (Munich) 1999; 94: 106–109.

14.

Feng

Wang

, et al. Acupuncture for chronic obstructive pulmonary disease (COPD): a multicenter, randomized, sham-controlled trial. Medicine 2016; 95(40): e4879.

15.

Suzuki

Muro

Ando

, et al. A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disease (COPD): the COPD-acupuncture trial (CAT). Arch Intern Med 2012; 172: 878–886.

16.

Coyle

Shergis

Huang

, et al. Acupuncture therapies for chronic obstructive pulmonary disease: a systematic review of randomized, controlled trials. Altern Ther Health Med 2014; 20(6): 10–23.

17.

Zhang

Qin

Geng

, et al. Electroacupuncture reduces hypothalamic and medullary expression of orexins and their receptors in a rat model of chronic obstructive pulmonary disease. Acupunct Med 2018; 36(5): 312–318.

18.

Cosio

Saetta

Agusti

Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360: 2445–2454.

19.

Prause

Bozinovski

Anderson

, et al. Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax 2004; 59: 313–317.

20.

Vargas-Rojas

Ramírez-Venegas

Limón-Camacho

, et al. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med 2011; 105(11): 1648–1654.

21.

Doe

Bafadhel

Siddiqui

, et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 2010; 138: 1140–1147.

22.

Chen

Thai

Zhao

, et al. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 2003; 278: 17036–17043.

23.

Chen

Liao

Gao

, et al. IL-17A induces pro-inflammatory cytokines production in macrophages via MAPKinases, NF-κB and AP-1. Cell Physiol Biochem 2013; 32(5): 1265–1274.

24.

Higaki

Wada

Mikura

, et al. Interleukin-10 modulates pulmonary neutrophilic inflammation induced by cigarette smoke exposure. Exp Lung Res 2015; 41(10): 525–534.

25.

Wang

Ying

Wang

, et al. Imbalance of peripheral blood Th17 and Treg responses in patients with chronic obstructive pulmonary disease. Clin Respir J 2015; 9(3): 330–341.

26.

Montalbano

Riccobono

Siena

, et al. Cigarette smoke affects IL-17A, IL-17F and IL-17 receptor expression in the lung tissue: ex vivo and in vitro studies. Cytokine 2015; 76(2): 391–402.

27.

Barin

Baldeviano

Talor

, et al. Macrophages participate in IL-17-mediated inflammation. Eur J Immunol 2012; 42(3): 726–736.

28.

Kaminska

MAPK signalling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta 2005; 1754: 253–262.

29.

Chunlian

Heyong

Jia

, et al. Magnolol inhibits tumor necrosis factor-α-induced ICAM-1 expression via suppressing NF-κB and MAPK signaling pathways in human lung epithelial cells. Inflammation 2014; 37: 1957–1967.

30.

Tan

Lam

KP.

Pharmacologic inhibition of MEK–ERK signaling enhances Th17 differentiation. J Immunol 2010; 184: e1849–e1857.

31.

Meshi

Vitalis

Ionescu

, et al. Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. Am J Respir Cell Mol Biol 2002; 26(1): 52–57.